Analysts tweak 12-month target prices on Fisher & Paykel Healthcare

Analysts tweak 12-month target prices on Fisher & Paykel Healthcare
(Image: Fisher & Paykel Healthcare)
Rebecca Howard
Analysts rejigged their 12-month target prices on Fisher & Paykel Healthcare after it lifted its full-year guidance but retained fairly downbeat ratings. Last Friday, the healthcare products manufacturer lifted its full-year revenue guidance to $1.73 billion, from $1.7b, and net profit to $260 million-$265m, from $250m-$260m.Forsyth Barr analysts lifted their target price to $23.45 from $22.95. The shares last traded at $26.62.They noted that F&P Healthcare referenced stronger hospital consumables revenue and “homecare r...

More Markets

NZ sharemarket up 0.1% on flat trading day
Markets Market close

NZ sharemarket up 0.1% on flat trading day

The S&P/NZX 50 Index closed at 11,790.92, up 14.18 points or 0.12%.

Advent International eyes NZ deals with Aussie outpost
Markets

Advent International eyes NZ deals with Aussie outpost

US private equity giant says NZ key market for growth.

These shares are 'priced for awful'
Markets

These shares are 'priced for awful'

Kathmandu, SkyCity and Fletcher shares are under pressure. Some are taking the plunge.